ASX:RMDHealth Care Equipment & ServicesHealth Care Equipment

RESMED CDI

$32.440

+$0.230 (+0.71%)

Day Range

$32.350 - $32.620

52 Week Range

$31.600 - $45.250

Volume

860.19K

Market Cap

$18.63B

Price Chart

Market Statistics

Open$32.600

Previous Close$32.210

Day High$32.620

Day Low$32.350

52 Week High$45.250

52 Week Low$31.600

Valuation

Market Cap18.63B

Shares Outstanding574.16M

Trading Activity

Volume860.19K

Value Traded27.91M

Bid$32.350 × 931

Ask$32.450 × 1,000

Technical Indicators

RSI (14)40.12

50-Day SMA$35.025

200-Day SMA$38.809

Weekly Wrap: Late pullback slams gold shares

ASX slips 0.7% as late pullback drags gold shares lower on Fed chair speculation; bullion drops ~5% amid rate-hike fears.

4 min read

John Beveridge

ASX 200Biotechnology

ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices

ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and software solutions. The company’s revenue for the period increased by 8% to US$1.3 billion (up 9% on a constant currency basis), while income from […]

2 min read

Imelda Cotton

ASX 200Technology

ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits

Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) could also help resolve sleep apnoea in some patients. California-based ResMed is a giant in the sleep apnoea space, manufacturing face masks, nasal devices and continuous positive airway pressure (PAP) […]

2 min read

Imelda Cotton